PharmaShots | Incisive News in 3 Shots

Subscribe Now

Pegloprastide

Avelas' AVB-620 (pegloprastide) Receives the US FDA's Breakthrough Therapy Designation for Use During Breast Cancer Surgery

Avelas' AVB-620 (pegloprastide) Receives the US FDA's Breakthrough Therapy Designation for Use During Breast Cancer Surgery

December 14, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us